Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 18, 2025 08:10 ET | Source: Quantum BioPharma

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

TORONTO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company...
September 18, 2025 08:00 ET | Source: Deep Isolation

Deep Isolation and Navarro Announce Strategic Licensing Agreement for Permanent Nuclear Waste Disposal

BERKELEY, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Deep Isolation Nuclear, Inc. (together with its subsidiaries “Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal...
September 18, 2025 06:00 ET | Source: Cavitation Technologies

Cavitation Technologies, Inc. Completes Exclusive Licensing Agreement with XYRA Corp. for Patented Cavitation Non-Thermal Plasma™ Technology

CHATSWORTH, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Cavitation Technologies, Inc. ("CTi" or the "Company") (OTCQB: CVAT), a leading provider of advanced fluid processing and water treatment...
September 16, 2025 08:00 ET | Source: Adagene Inc.

Adagene Expands SAFEbody® Collaboration and License Agreement with Exelixis to Develop Third Novel Masked Antibody-Drug Conjugate

SAN DIEGO and SUZHOU, China, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG) today announced an amendment to the 2021 collaboration and license agreement with Exelixis....
September 16, 2025 05:00 ET | Source: Italfarmaco

Italfarmaco Announces Exclusive Distribution Agreement with Multicare Pharma for DMD Treatment Givinostat in Brazil

Italfarmaco has entered into an agreement with Multicare for the regulatory approval and distribution of givinostat as a treatment for Duchenne muscular dystrophy in Brazil.MILAN, Italy, September 16,...
September 15, 2025 06:03 ET | Source: Ocugen

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

Upfront fees and near-term development milestone payments totaling up to $7.5 millionPotential sales milestones of $180 million or more in first 10 years of commercializationRoyalties equaling 25% of...
September 11, 2025 08:30 ET | Source: GCL Global Holdings Ltd.

GCL’s Subsidiary, 4Divinity, Secures Global Publishing Rights for ‘Kingdom Under Fire: The Civil War’

GCL’s Subsidiary, 4Divinity, Secures Global Publishing Rights for ‘Kingdom Under Fire: The Civil War’
September 10, 2025 07:03 ET | Source: Phononic Inc

Phononic Announces Exclusive Cold Chain Licensing Agreement with Peltier, Inc.

Phononic has licensed its cold chain cooling technology to Peltier, Inc.
September 08, 2025 08:31 ET | Source: Birchtech Corp.

Birchtech Secures License & Supply Bidding Agreements with Two Power Utilities

Birchtech Secures License & Supply Bidding Agreements with Two Power Utilities
September 08, 2025 07:00 ET | Source: Swift Fuels

Swift Fuels advances light gas (LG2F™) demonstration plant plans in Louisiana

Exclusivity agreement signed with Diamond Infrastructure Solutions for Swift Fuels to investigate its development and operation of a demonstration-scale unit Demonstration scale Light Gas to Fuels...